Guy P. Nohra, Alta Life Sciences

Guy P. Nohra, Managing Director of Barcelona-based Alta Life Sciences. See contact routes.

About Guy P. Nohra

Guy P. Nohra, Managing Director of Barcelona-based Alta Life Sciences, invests as a multistage fund across all development phases from seed to commercialization in biotechnology, biopharma, medical devices, diagnostics, genomics, and digital health. His distinctive thesis positions the firm as a bridge fund connecting the Spanish and European life sciences ecosystem with Silicon Valley’s venture capital expertise to drive US IPOs and global M&A exits. Notable portfolio companies include Peptomyc (cancer therapeutics), Bionure (central nervous system treatments), and Mediktor (digital health symptom checking). While specific check sizes are not publicly disclosed, Nohra leverages his prior experience managing $2 billion and investing in 200 companies at Alta Partners to lead investments with a hands-on approach.

Guy P. Nohra at a glance

Role
Managing Director
Organization
Alta Life Sciences
Location
Barcelona, Catalonia, Spain
Investor type
Venture Capital

Frequently asked about Guy P. Nohra

What does Guy P. Nohra invest in?
We have not verified a stated sector or stage focus for Guy P. Nohra at Alta Life Sciences (Barcelona, Catalonia, Spain). The profile lists the organization, location and investors we track alongside them.
How do I contact Guy P. Nohra?
Guy P. Nohra's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Guy P. Nohra based?
Guy P. Nohra is based in Barcelona, Catalonia, Spain.

StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Barcelona.

Investors similar to Guy P. Nohra (20)

Browse related investor lists (1)

Compare Guy P. Nohra (8)

Investors like Guy P. Nohra · Full investor directory · Investor access · Company funding database